← Back to Search

Cervical Cancer for Pancreatic Cancer (METEOR-CRATR Trial)

N/A
Recruiting
Led By Cliff Robinson, M.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from start of follow-up through completion of follow-up (estimated to be 5 years)
Awards & highlights

Summary

This study is a dynamically adjustable prospective longitudinal study designed to capture biospecimen (biopsy, blood, surgical) and multimodal treatment (imaging, dosimetry, clinical) data before, during, and after treatment with definitive-intent standard of care (SOC) radiotherapy for patients with locally advanced cervical and pancreatic cancer.

Eligible Conditions
  • Pancreatic Cancer
  • Cervical Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from start of follow-up through completion of follow-up (estimated to be 5 years)
This trial's timeline: 3 weeks for screening, Varies for treatment, and from start of follow-up through completion of follow-up (estimated to be 5 years) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in tumor microenvironment

Trial Design

2Treatment groups
Experimental Treatment
Group I: Pancreatic CancerExperimental Treatment3 Interventions
* Patients will have blood and tumor collected at various time points throughout participation in the study. * Patients will have standard of care imaging obtained at various time points and a diffusion basis spectrum imaging (DBSI) MRI will be obtained at the end of standard of care MRI.
Group II: Cervical CancerExperimental Treatment3 Interventions
* Patients will have blood and tumor collected at various time points throughout participation in the study. * Patients will have standard of care imaging obtained at various time points and a diffusion basis spectrum imaging (DBSI) MRI will be obtained at the end of standard of care MRI.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,940 Total Patients Enrolled
Washington University School of MedicineLead Sponsor
1,970 Previous Clinical Trials
2,308,563 Total Patients Enrolled
Cliff Robinson, M.D.Principal InvestigatorWashington University School of Medicine
3 Previous Clinical Trials
256 Total Patients Enrolled
~40 spots leftby Dec 2032
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top